Cancro Thomas 4
4 · DASAN ZHONE SOLUTIONS INC · Filed Dec 3, 2019
Insider Transaction Report
Form 4
Cancro Thomas
Chief Financial Officer
Transactions
- Award
Stock Option (Right to buy)
2019-12-02+160,000→ 0 totalExercise: $7.90Exp: 2029-12-02→ Common Stock (160,000 underlying)
Footnotes (1)
- [F1]The Option will vest over a four year vesting schedule as follows: twenty five percent (25%) of the Option will vest on the first (1st) anniversary of the grant date or December 2, 2020, and the remainder will vest in thirty-six (36) monthly installments thereafter.